Skip to main content
FastDOL

GENENTECH is a research and development in biotechnology (except nanobiotechnology) employer in SOUTH SAN FRANCISCO, CA. Federal records show 13 OSHA inspections with 2 violations and $600 in penalties. All data sourced from public federal enforcement records.

Data sourced from OSHA, DOL WHD, MSHA, EPA ECHO, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA, and the UVA Corporate Prosecution Registry. Last updated: May 2, 2026.

GENENTECH

325 DNA WAY, SOUTH SAN FRANCISCO, CA, 94080

541714 — Top companies in Research and Development in Biotechnology (except Nanobiotechnology)

12,651 employees

Federal Enforcement
13
OSHA inspections
2 violations
$600 in penalties
1 hospitalizations

Industry Benchmark

Industry Avg TRIR
0.6
Industry Avg DART
0.3
Self-Reported DART
0.4
Self-Reported TRIR
1.1
Industry rates from BLS SOII 2024. Self-reported rates from OSHA ITA Form 300A (employer self-reported).
OSHA Inspections
13
OSHA Violations
2
Total Penalties
$600
Trend
STABLE
WHD Cases
0
Back Wages Owed
$0
Confidence
HIGH
SVEP Flag
No
Visa Applications
25
Visa Certified
24

Data Insights

History Span
29 years
Last Activity
221 days ago
Inspection Rate
0.4/yr
Violation Rate
0.1/yr
Violation Severity Mix
$300 avg per violation$46 avg per inspection
Active Agencies:
OSHA$13,600 total across all agencies
TRIR vs Industry Avg
+0.5
Above industry average
DART vs Industry Avg
+0.1
Above industry average

CPSC Product Recalls

Consumer Product Safety Commission recall history matched on company name.
0
Total Recalls
1
Last 5 Years
0
Last 12 Months
0
Units Recalled
0
Top Hazard: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Most Recent Recall: 2021-03-18

Inspection Breakdown

Planned
1
Complaint
9
Accident
2
Complaint and accident-triggered inspections are stronger risk signals than routine planned inspections.
Violation rate: 8% of inspections

Peer Comparison

68%
Above average violations
vs 163 employers in same industry & state
Fewer violationsMore violations
Penalty Percentile
73%
Inspection Frequency Percentile
100%

Visa & Labor Certification (OFLC)

Total Applications
25
Certified
24
Avg Wage Ratio
1.08x
H-1BE-3 Australian
Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage.

Environmental Compliance (EPA)

EPA Inspections
3
Quarters Non-Compliant
0
Formal Actions
2
EPA Penalties
$13,000
Status: No Violation Identified
EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act.

Motor Carrier Safety (FMCSA)

DOT Number
481510
Operation Type
B
Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.

Need API access, CSV upload, or PDF reports? Upgrade to Paid for $79/mo.

Inspection History

No inspection records found.

Related Searches

More in Research and Development in Biotechnology (except Nanobiotechnology)Similar employers in CAResearch and Development in CA
Loading news...

The FastDOL Report

Weekly workplace compliance news. Free.

More employers in this state: California workplace enforcement data →
More in this industry: Research and Development in Biotechnology (except Nanobiotechnology) enforcement data →

Data aggregated from public federal enforcement and program records (OSHA, WHD, MSHA, EPA, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA) plus the UVA Corporate Prosecution Registry. Employer profiles matched by name and location — matching errors may occur. Risk scores computed by FastDOL, not official government assessments. OSHA citations typically appear 3-8 months after the inspection, so very recent enforcement actions may not yet be reflected. Data provided as-is. Report a data error.

Other employers in Research and Development in Biotechnology (except Nanobiotechnology) within CA

Industry context

Within the research and development in biotechnology (except nanobiotechnology) industry in CA, GENENTECH ranks in the 68th percentile of OSHA violation frequency across 163 comparable establishments.

OSHA penalty totals rank in the 73th percentile of the same peer group. Inspection frequency ranks in the 100th percentile.

The Bureau of Labor Statistics reports an industry-average Total Recordable Incident Rate (TRIR) of 0.6 for the research and development in biotechnology (except nanobiotechnology) sector, with a Days Away, Restricted, or Transferred (DART) rate of 0.3. GENENTECH's self-reported DART rate is 0.4, which is above the industry average.

Activity timeline

Frequently Asked Questions

What is GENENTECH's OSHA violation history?
GENENTECH has 13 OSHA inspections on record with 2 violations and $600 in total penalties.
How does GENENTECH's safety record compare to its industry?
GENENTECH operates in the research and development in biotechnology (except nanobiotechnology) industry. The industry average Total Recordable Incident Rate (TRIR) is 0.6. GENENTECH's self-reported DART rate is 0.4 compared to an industry average of 0.3.

About this data

This profile aggregates federal enforcement records on GENENTECH of SOUTH SAN FRANCISCO, CA from 17 federal data sources. Records were found in 6 sources: OSHA workplace safety inspections, EPA ECHO environmental compliance, OFLC visa-program filings, FMCSA motor carrier safety, CPSC consumer-product recalls, and BLS industry safety benchmarks. The remaining 11 sources were checked and found no matching records: WHD, MSHA, NLRB, OFCCP, USAspending, SAM.gov, CMS, NHTSA, UVA, SEC enforcement, SEC facts.

Establishments are matched across agencies using normalized employer name, state, and ZIP code. The dataset was last refreshed on May 2, 2026. OSHA accident records on file for GENENTECH include 1 hospitalization.

This profile may be incomplete if GENENTECHoperates under multiple legal names, files under variations our entity-matching rules don't yet cover, or maintains records below current matching thresholds. To report a missing record or correction, email corrections@fastdol.com.